Interferon-γ has been shown to protect mice from influenza virus if administrated at an early stage of infection (Sainz et al. 2004; Weiss et al. 2010), and genetic variation within the IFNG gene has been linked to SARS in humans (Chong et al. 2006). This evidence concerns the gene IFNG and infection.